NKTR-255 enhances complete response following CD19 CAR T-cell therapy in patients with relapsed/refractory large

Sairah Ahmed1, John F DiPersio2, James H Essell3

  • 1Division of Cancer Medicine, Departments of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX.

Blood Advances
|August 8, 2025
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos